Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew G L Douglas

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Non-Coding RNA Research|December 12, 2018
Non-coding RNA in <i>C9orf72</i>-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunctionAndrew G L Douglas
European Journal of Human Genetics : EJHG|June 2, 2025
Penetrance and pleiotropy in ATXN2-related amyotrophic lateral sclerosisAndrew G L Douglas
BMJ (Clinical Research Ed.)|May 27, 2010
Modern genetics. No blind alleys in the clinicAndrew G L Douglas
Journal of Medical Genetics|December 20, 2023
Reduced penetrance of gene variants causing amyotrophic lateral sclerosisAndrew G L Douglas, Diana Baralle
Clinical Dysmorphology|December 3, 2009
Extending the phenotypic spectrum of CHARGE syndrome: a case with preaxial polydactylyAndrew G L Douglas, Wayne Lam
The International Journal of Biochemistry & Cell Biology|December 31, 2018
RNA splicing analysis in genomic medicineHtoo Wai, Andrew G L Douglas, Diana Baralle
Molecular and Cellular Neurosciences|May 2, 2013
Splicing therapy for neuromuscular diseaseAndrew G L Douglas, Matthew J A Wood
Briefings in Functional Genomics|June 2, 2011
RNA splicing: disease and therapyAndrew G L Douglas, Matthew J A Wood
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2024
Perils of predictive testing for unaffected people from motor neuron disease families with no identified causal geneAlisdair Mcneill, Andrew G L Douglas, Rhona Macleod, et al.
BMJ Neurology Open|September 24, 2024
Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementiaAndrew G L Douglas, Alexander G Thompson, Martin R Turner, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Non-Coding RNA Research|December 12, 2018
Non-coding RNA in <i>C9orf72</i>-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunctionAndrew G L Douglas
European Journal of Human Genetics : EJHG|June 2, 2025
Penetrance and pleiotropy in ATXN2-related amyotrophic lateral sclerosisAndrew G L Douglas
BMJ (Clinical Research Ed.)|May 27, 2010
Modern genetics. No blind alleys in the clinicAndrew G L Douglas
Journal of Medical Genetics|December 20, 2023
Reduced penetrance of gene variants causing amyotrophic lateral sclerosisAndrew G L Douglas, Diana Baralle
Clinical Dysmorphology|December 3, 2009
Extending the phenotypic spectrum of CHARGE syndrome: a case with preaxial polydactylyAndrew G L Douglas, Wayne Lam
The International Journal of Biochemistry & Cell Biology|December 31, 2018
RNA splicing analysis in genomic medicineHtoo Wai, Andrew G L Douglas, Diana Baralle
Molecular and Cellular Neurosciences|May 2, 2013
Splicing therapy for neuromuscular diseaseAndrew G L Douglas, Matthew J A Wood
Briefings in Functional Genomics|June 2, 2011
RNA splicing: disease and therapyAndrew G L Douglas, Matthew J A Wood
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2024
Perils of predictive testing for unaffected people from motor neuron disease families with no identified causal geneAlisdair Mcneill, Andrew G L Douglas, Rhona Macleod, et al.
BMJ Neurology Open|September 24, 2024
Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementiaAndrew G L Douglas, Alexander G Thompson, Martin R Turner, et al.
Pageof 4